Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: Correlation with circulating interleukin-6 activity

Journal of Interferon and Cytokine Research

Volumn 23, Issue 6, 2003, Pages 329-333

  Parissis, John T ^a   Adamopoulos, Stamatis N ^b   Venetsanou, Koula F ^a   Karas, Spilios M ^a   Kremastinos, Dimitrios T ^b  

^a AMALIA FLEMING GENERAL HOSPITAL   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 6; NEUROHORMONE; NORADRENALIN; RENIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AMYLASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HORMONE ACTION; HUMAN; MALE; NORADRENALIN BLOOD LEVEL; ORGAN INJURY; PRIORITY JOURNAL; UNITED STATES; VENOUS PRESSURE;

AMYLASES; CARDIAC OUTPUT, LOW; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; PROSPECTIVE STUDIES;

EID: 0038205801     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999003766628179     Document Type: Article

References (21)

1. PACKER, M. (1992). The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J. Am. Coll. Cardiol. 20, 248-254.
2. MANN, D.L. (1999). Mechanisms and models in heart failure: a combinatorial approach. Circulation 100, 999-1008.
3. MANN, D.L., and YOUNG, J.B. (1994). Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest 105, 897-904.
4. VANDERHEYDEN, M., KERSSCHOF, E., and PAULUS, W.J. (1998). Proinflammatory cytokines and endothelium-dependent vasodilation in the forearm: serial assessment in patients with congestive heart failure. Eur. Heart. J. 19, 747-752.
5. NIEBAUER, J., VOLK, H.D., KEMP, M., DOMINGUEZ, M., SCHUMANN, R.R., RAUCHHAUS, M., POOLE-WILSON, P.A., COATS, A.J., and ANKER, S.D. (1999). Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353, 1838-1842.
6. ANKER, S.D., and RAUCHHAUS, M. (1999). Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. Curr. Opin. Cardiol. 14, 211-216.
7. YAN, S.F., TRITTO, I., PINSKY, D., LIAO, H., HUANG, J., and FULLER, G. (1995). Induction of interleukin-6 (IL-6) by hypoxia in vascular cells. J. Biol. Chem. 270, 11463-11471.
8. DAVIES, G.C., KISSINGER, P., and SHOU, R. (1981). Strategies for determination of serum or plasma norepinephrine by reverse phase liquid chromatography. Anal. Chem. 53, 156-159.
9. HABER, E., KOERNER, J., PAGE, L.B., KLIMAN, B.M., and PURVODE, A. (1969). Application of a radioimmunoassay for angiotensin 1 to physiological measurements of plasma renin activity in normal subjects. J. Clin. Metab. 29, 1349-1355.
10. LEVINE, B., KALMAN, J., MAYER, L., FILLIT, H.M., and PACKER, M. (1990). Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 323, 236-241.
11. TORRE-AMIONE, G., KAPADIA, S., BENEDICT, C., ORAL, H., YOUNG, J.B., and MANN, D.L. (1996). Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J. Am. Coll. Cardiol. 2, 2101-2106.
12. MACGOWAN, G.A., MANN, D.L., KORMOS, R.L., FELDMAN, A.M., and MURALI, S. (1997). Circulating interleukin-6 in severe heart failure. Am. J. Cardiol. 79, 1128-1131.
13. PARISSIS, J., ADAMOPOULOS, S., VENETSANOU, K., MENTZIKOF, D., KARAS, S., and KREMASTINOS, D. (2000). Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 86, 707-710.
14. LOMMI, J., PULKKI, K., KOSKINEN, P., NAVERI, H., LEINONEN, H., HARKONEN, M., and KUPARI, M. (1997). Hemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure. Eur. Heart J. 18, 1620-1625.
15. TSUTAMOTO, T., HISANAGA, T., WADA, A., MAEDA, K., OHNISHI, M., FUKAI, D., MABUCHI, N., SAWAKI, M., and KINOSHITA, M. (1998). Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure. J. Am. Coll. Cardiol. 31, 391-398.
16. PAULUS, W.J. (1999). How are cytokines activated in heart failure? Eur. J. Heart. Fail. 1, 309-312.
17. TORRE-AMIONE, G., KAPADIA, S., LEE, J., DURAND, J.B., BIES, R.D., YOUNG, J.B., and MANN, D.L. (1996). Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation 93, 704-711.
18. HABIB, F.M, SPRIGNALL, D.R, DAVIES, G.J, OAKLEY, C.M, YACOUB, M.H., and POLAK, J.M. (1996). Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347, 1151-1155.
19. ANKER, S.D, EGERER, K.R, VOLK, H.D, KOX, W.J, POOLE-WILSON, P.A, and COATS, A.J.S. (1997). Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am. J. Cardiol. 79, 1426-1429.
20. ANKER, S.D., VOLTERRANI, M., EGERER, K.R., FELTON, C.V., KOX, W.J., POOLE-WILSON, P.A., and COATS, A.J.S. (1998). Tumor necrosis factor-α as a predictor of peak leg blood flow in patients with chronic heart failure. Q. J. Med. 91, 199-203.
21. ADAMOPOULOS, S., PARISSIS, J., and KREMASTINOS, D. (2002). Endothelial dysfunction in chronic heart failure: clinical and therapeutic implications. Eur. J. Intern. Med. 13, 356-364.